Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Dec;102(3):523–528. doi: 10.1111/j.1365-2249.1995.tb03847.x

Immune responsiveness in Mycobacterium avium-infected mice: changes in the proportion of T cell subsets and antibody production during the course of infection.

D L Xu 1, Y Goto 1, K K Amoako 1, T Nagatomo 1, K Uchida 1, T Shinjo 1
PMCID: PMC1553374  PMID: 8536367

Abstract

The C57Bl/6 susceptible (Bcgs) and its resistant (Bcgr) congenic mouse, previously developed by retrogressive backcrossing, were infected with 1 x 10(6) colony-forming units (CFU) of Mycobacterium avium and bacterial growth and their immune responses during the early and prolonged periods of infection were examined. There was a high proliferation in the liver and spleen of Bcgs mice, whereas no proliferation was observed in the Bcgr mice. Similarly, the sizes and weights of these organs were much higher than those of their Bcgr counterparts. The size and number of granulomas in Bcgs were also found to be higher than those of Bcgr. The CD3+ and CD4+ subsets increased dramatically in both mice during the early stage of infection. However, in the later phase of the infection, these populations decreased dramatically in Bcgs mice, but not in Bcgr mice, resulting in a depression in cell-mediated immune responses. No significant decrease in cell-mediated immune responses was observed in Bcgr mice even after prolonged infection. ELISA was performed to determine the antibody levels in both mice, and it was found that serum IgG and IgM levels in Bcgs were comparatively higher than those in Bcgr mice throughout the period of infection. The Bcg gene therefore may have an important role in the maintenance of resistance not only in the early phase but also in the later phase of Myco. avium infection.

Full text

PDF
523

Images in this article

526Fig. 5
on p.526

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appelberg R., Castro A. G., Pedrosa J., Silva R. A., Orme I. M., Minóprio P. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect Immun. 1994 Sep;62(9):3962–3971. doi: 10.1128/iai.62.9.3962-3971.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bradley D. J., Kirkley J. Regulation of Leishmania populations within the host. I. the variable course of Leishmania donovani infections in mice. Clin Exp Immunol. 1977 Oct;30(1):119–129. [PMC free article] [PubMed] [Google Scholar]
  3. Bullock W. E., Jr, Fasal P. Studies of immune mechanisms in leprosy. 3. The role of cellular and humoral factors in impairment of the in vitro immune response. J Immunol. 1971 Apr;106(4):888–899. [PubMed] [Google Scholar]
  4. Cheers C., McKenzie I. F. Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis. Infect Immun. 1978 Mar;19(3):755–762. doi: 10.1128/iai.19.3.755-762.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chin D. P., Reingold A. L., Stone E. N., Vittinghoff E., Horsburgh C. R., Jr, Simon E. M., Yajko D. M., Hadley W. K., Ostroff S. M., Hopewell P. C. The impact of Mycobacterium avium complex bacteremia and its treatment on survival of AIDS patients--a prospective study. J Infect Dis. 1994 Sep;170(3):578–584. doi: 10.1093/infdis/170.3.578. [DOI] [PubMed] [Google Scholar]
  6. Chlebowski R. T., Grosvenor M. B., Bernhard N. H., Morales L. S., Bulcavage L. M. Nutritional status, gastrointestinal dysfunction, and survival in patients with AIDS. Am J Gastroenterol. 1989 Oct;84(10):1288–1293. [PubMed] [Google Scholar]
  7. Denis M., Forget A., Pelletier M., Skamene E. Pleiotropic effects of the Bcg gene: III. Respiratory burst in Bcg-congenic macrophages. Clin Exp Immunol. 1988 Sep;73(3):370–375. [PMC free article] [PubMed] [Google Scholar]
  8. Denis M., Forget A., Pelletier M., Turcotte R., Skamene E. Control of the Bcg gene of early resistance in mice to infections with BCG substrains and atypical mycobacteria. Clin Exp Immunol. 1986 Mar;63(3):517–525. [PMC free article] [PubMed] [Google Scholar]
  9. Forget A., Skamene E., Gros P., Miailhe A. C., Turcotte R. Differences in response among inbred mouse strains to infection with small doses of Mycobacterium bovis BCG. Infect Immun. 1981 Apr;32(1):42–47. doi: 10.1128/iai.32.1.42-47.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Gangadharam P. R., Edwards C. K., 3rd, Murthy P. S., Pratt P. F. An acute infection model for Mycobacterium intracellulare disease using beige mice: preliminary results. Am Rev Respir Dis. 1983 May;127(5):648–649. doi: 10.1164/arrd.1983.127.5.648. [DOI] [PubMed] [Google Scholar]
  11. Goto Y., Buschman E., Skamene E. Regulation of host resistance to Mycobacterium intracellulare in vivo and in vitro by the Bcg gene. Immunogenetics. 1989;30(3):218–221. doi: 10.1007/BF02421210. [DOI] [PubMed] [Google Scholar]
  12. Goto Y., Nakamura R. M., Takahashi H., Tokunaga T. Genetic control of resistance to Mycobacterium intracellulare infection in mice. Infect Immun. 1984 Oct;46(1):135–140. doi: 10.1128/iai.46.1.135-140.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gros P., Skamene E., Forget A. Cellular mechanisms of genetically controlled host resistance to Mycobacterium bovis (BCG). J Immunol. 1983 Oct;131(4):1966–1972. [PubMed] [Google Scholar]
  14. Gros P., Skamene E., Forget A. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J Immunol. 1981 Dec;127(6):2417–2421. [PubMed] [Google Scholar]
  15. Hubbard R. D., Flory C. M., Collins F. M. T-cell immune responses in Mycobacterium avium-infected mice. Infect Immun. 1992 Jan;60(1):150–153. doi: 10.1128/iai.60.1.150-153.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Huygen K., Van Vooren J. P., Turneer M., Bosmans R., Dierckx P., De Bruyn J. Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand J Immunol. 1988 Feb;27(2):187–194. doi: 10.1111/j.1365-3083.1988.tb02338.x. [DOI] [PubMed] [Google Scholar]
  17. Kramnik I., Radzioch D., Skamene E. T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice. Immunology. 1994 Apr;81(4):618–625. [PMC free article] [PubMed] [Google Scholar]
  18. Lenzini L., Rottoli P., Rottoli L. The spectrum of human tuberculosis. Clin Exp Immunol. 1977 Feb;27(2):230–237. [PMC free article] [PubMed] [Google Scholar]
  19. McMurray D. N., Echeverri A. Cell-mediated immunity in anergic patients with pulmonary tuberculosis. Am Rev Respir Dis. 1978 Nov;118(5):827–834. doi: 10.1164/arrd.1978.118.5.827. [DOI] [PubMed] [Google Scholar]
  20. Mosmann T. R. Cytokines: is there biological meaning? Curr Opin Immunol. 1991 Jun;3(3):311–314. doi: 10.1016/0952-7915(91)90029-z. [DOI] [PubMed] [Google Scholar]
  21. Nakamura R. M., Goto Y., Kitamura K., Tokunaga T. Two types of suppressor T cells that inhibit delayed-type hypersensitivity to Mycobacterium intracellulare in mice. Infect Immun. 1989 Mar;57(3):779–784. doi: 10.1128/iai.57.3.779-784.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Nakamura R. M., Tokunaga T. Induction of suppressor T cells in delayed-type hypersensitivity to Mycobacterium bovis BCG in low-responder mice. Infect Immun. 1980 May;28(2):331–335. doi: 10.1128/iai.28.2.331-335.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Orme I. M., Collins F. M. Demonstration of acquired resistance in Bcgr inbred mouse strains infected with a low dose of BCG montreal. Clin Exp Immunol. 1984 Apr;56(1):81–88. [PMC free article] [PubMed] [Google Scholar]
  24. Orme I. M., Furney S. K., Roberts A. D. Dissemination of enteric Mycobacterium avium infections in mice rendered immunodeficient by thymectomy and CD4 depletion or by prior infection with murine AIDS retroviruses. Infect Immun. 1992 Nov;60(11):4747–4753. doi: 10.1128/iai.60.11.4747-4753.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Orme I. M., Stokes R. W., Collins F. M. Genetic control of natural resistance to nontuberculous mycobacterial infections in mice. Infect Immun. 1986 Oct;54(1):56–62. doi: 10.1128/iai.54.1.56-62.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pelletier M., Forget A., Bourassa D., Gros P., Skamene E. Immunopathology of BCG infection in genetically resistant and susceptible mouse strains. J Immunol. 1982 Nov;129(5):2179–2185. [PubMed] [Google Scholar]
  27. Plant J., Glynn A. A. Natural resistance to Salmonella infection, delayed hypersensitivity and Ir genes in different strains of mice. Nature. 1974 Mar 22;248(446):345–347. doi: 10.1038/248345a0. [DOI] [PubMed] [Google Scholar]
  28. Skamene E., Gros P., Forget A., Kongshavn P. A., St Charles C., Taylor B. A. Genetic regulation of resistance to intracellular pathogens. Nature. 1982 Jun 10;297(5866):506–509. doi: 10.1038/297506a0. [DOI] [PubMed] [Google Scholar]
  29. Skamene E., Gros P., Forget A., Patel P. J., Nesbitt M. N. Regulation of resistance to leprosy by chromosome 1 locus in the mouse. Immunogenetics. 1984;19(2):117–124. doi: 10.1007/BF00387854. [DOI] [PubMed] [Google Scholar]
  30. Stach J. L., Gros P., Forget A., Skamene E. Phenotypic expression of genetically-controlled natural resistance to Mycobacterium bovis (BCG). J Immunol. 1984 Feb;132(2):888–892. [PubMed] [Google Scholar]
  31. Stokes R. W., Collins F. M. Passive transfer of immunity of Mycobacterium avium in susceptible and resistant strains of mice. Clin Exp Immunol. 1990 Jul;81(1):109–115. doi: 10.1111/j.1365-2249.1990.tb05299.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Stokes R. W., Orme I. M., Collins F. M. Role of mononuclear phagocytes in expression of resistance and susceptibility to Mycobacterium avium infections in mice. Infect Immun. 1986 Dec;54(3):811–819. doi: 10.1128/iai.54.3.811-819.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Sánchez F. O., Rodríguez J. I., Agudelo G., García L. F. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls. Infect Immun. 1994 Dec;62(12):5673–5678. doi: 10.1128/iai.62.12.5673-5678.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Vidal S. M., Malo D., Vogan K., Skamene E., Gros P. Natural resistance to infection with intracellular parasites: isolation of a candidate for Bcg. Cell. 1993 May 7;73(3):469–485. doi: 10.1016/0092-8674(93)90135-d. [DOI] [PubMed] [Google Scholar]
  35. Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis. 1979 Jan;119(1):107–159. doi: 10.1164/arrd.1979.119.1.107. [DOI] [PubMed] [Google Scholar]
  36. Zwilling B. S., Vespa L., Massie M. Regulation of I-A expression by murine peritoneal macrophages: differences linked to the Bcg gene. J Immunol. 1987 Mar 1;138(5):1372–1376. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES